In an unprecedented move, President Donald Trump's fiscal strategy for 2026 proposes a staggering $18 billion reduction in health research funding from the U.S. National Institutes of Health (NIH), sending shockwaves through the academic radiology community. Researchers face intense financial
Recent legal actions by major drug manufacturers, such as Eli Lilly, highlight growing concerns over the ethics and legality associated with telehealth companies and compounding pharmacies involved in providing compounded diabetes and weight-loss medications. These developments underscore a
The integration of artificial intelligence into the realm of biological research represents a seismic shift in scientific processes and methodologies. This evolution is vividly illustrated by the experiences of Malek Elsayyid, a graduate student from the University of Delaware, whose academic
The concept that "prevention is better than cure" has been an essential directive in healthcare for centuries. This age-old wisdom finds new relevance as advances in artificial intelligence (AI) make early detection and intervention more achievable. AI technologies promise to reshape
Advancements in healthcare technology have taken a significant leap forward with the introduction of Cancer 360 by the UK's National Health Service (NHS). This groundbreaking tool, designed to improve cancer diagnosis and treatment, integrates seamlessly into the federated data platform (FDP).
In the rapidly evolving field of medical research, a new compound known as DT-109 has emerged as a beacon of hope for patients suffering from heart and liver diseases. Developed at the University of Michigan, this glycine-based compound was initially created to tackle metabolic
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30